⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS ® (denosumab injection) and TUZEMTY ® (denosumab injection), Biosimilars to PROLIA and XGEVA
businesswire.com
OGN
Organon Canada et Henlius élargissent l’accès aux traitements à base de dénosumab avec le lancement de BILDYOS® (injection de dénosumab) et de TUZEMTY® (injection de dénosumab), des biosimilaires de PROLIA et de XGEVA
businesswire.com
OGN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
globenewswire.com
APGE
ROKU
TBRG
OGN
ABBV
FOXA
Organon Completes Agreement to License MIUDELLA ®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
businesswire.com
OGN
Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA ® (ustékinumab), un biosimilaire de référence à STELARA ® (ustékinumab) au Canada
businesswire.com
OGN
Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada
businesswire.com
OGN
Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders
globenewswire.com
LPRO
NUVL
OGN
SUNE
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
globenewswire.com
SLP
ROKU
TBRG
OGN
Form 8-K
sec.gov
OGN
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19
businesswire.com
OGN